Elevated expression of AARS1 and lactylation of p53 are often associated with poor prognosis of patients, and administration of β-alanine to antagonize the lactylation of p53, coupled with doxorubicin to activate the transcriptional activity of p53, can significantly inhibit the proliferation of tumor cells in animal models [23]. The gene discussed is AARS1; the disease is neoplasm.